Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and dr… Read more
Apotea (APOTEA) - Net Assets
Latest net assets as of : Skr- SEK
Based on the latest financial reports, Apotea (APOTEA) has net assets worth Skr- SEK as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr-) and total liabilities (Skr-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Apotea - Net Assets Trend (None–None)
This chart illustrates how Apotea's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Apotea (None–None)
The table below shows the annual net assets of Apotea from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Apotea's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Apotea Competitors by Market Cap
The table below lists competitors of Apotea ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shandong Xinneng Taishan Power Generation Co Ltd
SHE:000720
|
$364.23 Million |
|
PolyPeptide Group AG
SW:PPGN
|
$364.27 Million |
|
Bio-Thera Solutions Ltd
SHG:688177
|
$364.33 Million |
|
Colony Bankcorp Inc.
NYSE:CBAN
|
$364.40 Million |
|
Universal Cement Corp
TW:1104
|
$364.13 Million |
|
Elecon Engineering Company Limited
NSE:ELECON
|
$364.11 Million |
|
Zhejiang He Chuan Technology Corp. Ltd. A
SHG:688320
|
$364.07 Million |
|
Hubei Xiangyuan New Material Technology Inc.
SHE:300980
|
$363.98 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Apotea's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Apotea's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Apotea utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Apotea's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
No peer company data available for comparison.